{"title":"Prevalence and predictors of potentially inappropriate medication in older adults hospitalized with cardiovascular disease.","authors":"Rishabh Sharma, Parveen Bansal, Pranav Rathore, Nahush Bansal, Aditi Rathore, Malika Arora","doi":"10.4103/jfmpc.jfmpc_1865_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The use of potentially inappropriate medications (PIMs) is a significant concern among older adults with cardiovascular disease (CVD) as it can lead to adverse drug events, increased hospitalizations, and poorer health outcomes. Despite the known risks, limited evidence exists on predictors of PIM use in this population.</p><p><strong>Objective: </strong>To determine the prevalence and predictors of PIM use in the older adult patients hospitalized with CVD.</p><p><strong>Methods: </strong>This prospective cross-sectional study included 250 older adult patients (mean age 69.03 ± 5.76 years) with the CVD, admitted to the cardiology/medicine department of a tertiary care hospital. PIMs were identified as per Beers criteria<sup>®</sup> 2019. Binary logistic regression analysis was used to determine the predictors of PIM use.</p><p><strong>Results: </strong>The PIM prescription rate was 62.4% (<i>n</i> = 156) with a proton pump inhibitor, short acting insulin according to sliding scale, and Enoxaparin <30 mL/min as the most prescribed PIM. Predictors for PIMs use were found to be females (odds ratio [OR] 2.36, 95% confidence interval (CI) 1.36-4.09, <i>P</i> = 0.002), three diagnosis (OR 4.29, 95% CI 1.31-14.0, <i>P</i> = 0.016), ≥4 diagnosis (OR 4.8, 95% CI 1.49-15.44, <i>P</i> = 0.009), 7-9 days of hospital stay (OR 4.74, 95% CI 1.07-20.96, <i>P</i> = 0.04), and ≥9 medications per day (OR 0.09, 95% CI 0.01-0.50, <i>P</i> = 0.006).</p><p><strong>Conclusion: </strong>PIM prevalence in older adults with CVD is very high, and females with CVD have emerged as a potential PIM indicator. The study also indicates a lack of awareness toward Beers criteria<sup>®</sup> in health care workers (physicians/pharmacists/nursing staff) leading to PIM.</p>","PeriodicalId":15856,"journal":{"name":"Journal of Family Medicine and Primary Care","volume":"14 9","pages":"4027-4034"},"PeriodicalIF":1.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12517658/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Family Medicine and Primary Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jfmpc.jfmpc_1865_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The use of potentially inappropriate medications (PIMs) is a significant concern among older adults with cardiovascular disease (CVD) as it can lead to adverse drug events, increased hospitalizations, and poorer health outcomes. Despite the known risks, limited evidence exists on predictors of PIM use in this population.
Objective: To determine the prevalence and predictors of PIM use in the older adult patients hospitalized with CVD.
Methods: This prospective cross-sectional study included 250 older adult patients (mean age 69.03 ± 5.76 years) with the CVD, admitted to the cardiology/medicine department of a tertiary care hospital. PIMs were identified as per Beers criteria® 2019. Binary logistic regression analysis was used to determine the predictors of PIM use.
Results: The PIM prescription rate was 62.4% (n = 156) with a proton pump inhibitor, short acting insulin according to sliding scale, and Enoxaparin <30 mL/min as the most prescribed PIM. Predictors for PIMs use were found to be females (odds ratio [OR] 2.36, 95% confidence interval (CI) 1.36-4.09, P = 0.002), three diagnosis (OR 4.29, 95% CI 1.31-14.0, P = 0.016), ≥4 diagnosis (OR 4.8, 95% CI 1.49-15.44, P = 0.009), 7-9 days of hospital stay (OR 4.74, 95% CI 1.07-20.96, P = 0.04), and ≥9 medications per day (OR 0.09, 95% CI 0.01-0.50, P = 0.006).
Conclusion: PIM prevalence in older adults with CVD is very high, and females with CVD have emerged as a potential PIM indicator. The study also indicates a lack of awareness toward Beers criteria® in health care workers (physicians/pharmacists/nursing staff) leading to PIM.
使用潜在不适当的药物(PIMs)是老年心血管疾病(CVD)患者关注的一个重要问题,因为它可能导致药物不良事件、住院率增加和健康结果变差。尽管存在已知的风险,但在该人群中使用PIM的预测因素方面存在有限的证据。目的:了解老年心血管疾病住院患者PIM的使用情况及预测因素。方法:本前瞻性横断面研究纳入某三级医院心内科收治的250例老年心血管病患者(平均年龄69.03±5.76岁)。pim是根据Beers标准®2019确定的。采用二元logistic回归分析确定PIM使用的预测因素。结果:PIM处方率为62.4% (n = 156),其中质子泵抑制剂、短效胰岛素(滑动量表)和依诺肝素(P = 0.002)、3次诊断(OR 4.29, 95% CI 1.31-14.0, P = 0.016)、≥4次诊断(OR 4.8, 95% CI 1.49-15.44, P = 0.009)、7-9天住院(OR 4.74, 95% CI 1.07-20.96, P = 0.04)、每天≥9次用药(OR 0.09, 95% CI 0.01-0.50, P = 0.006)。结论:老年CVD患者PIM患病率非常高,女性CVD患者已成为PIM的潜在指标。该研究还表明,卫生保健工作者(医生/药剂师/护理人员)缺乏对比尔斯标准®的认识,导致PIM。